Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Di Perri

Showing results (281-290 of 358) with videos related to

Pageof 36
Sort By:
International Journal of Antimicrobial Agents|February 4, 2021
Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses?Alice Trentalange, Enrica Borgogno, Ilaria Motta, et al.
AIDS Research and Human Retroviruses|July 14, 2015
HIV-1 Very Low Level Viremia Is Associated with Virological Failure in Highly Active Antiretroviral Treatment-Treated PatientsAndrea Calcagno, Ilaria Motta, Valeria Ghisetti, et al.
Antibiotics (Basel, Switzerland)|December 23, 2022
Pharmacokinetic of Cefiderocol in Critically Ill Patients Receiving Renal Replacement Therapy: A Case SeriesSimone Mornese Pinna, Silvia Corcione, Amedeo De Nicolò, et al.
Journal of Pharmacological and Toxicological Methods|August 31, 2018
A simple UHPLC-PDA method with a fast dilute-and-shot sample preparation for the quantification of canrenone and its prodrug spironolactone in human urine samplesValeria Avataneo, Amedeo De Nicolò, Franco Rabbia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From AntiretroviralsGuglielmo Nasti, Renato Talamini, Andrea Antinori, et al.
Current HIV Research|May 14, 2008
HIV-1 residual viremia and proviral DNA in patients with suppressed plasma viral load (<400 HIV-RNA cp/ml) during different antiretroviral regimensEmanuele Nicastri, Lucia Palmisano, Loredana Sarmati, et al.
AIDS (London, England)|November 26, 2019
Presence of Epstein-Barr virus DNA in cerebrospinal fluid is associated with greater HIV RNA and inflammationTommaso Lupia, Maria Grazia Milia, Cristiana Atzori, et al.
Pharmaceutics|September 23, 2022
Clinical Effectiveness and Pharmacokinetics of Dalbavancin in Treatment-Experienced Patients with Skin, Osteoarticular, or Vascular InfectionsGiacomo Stroffolini, Amedeo De Nicolò, Alberto Gaviraghi, et al.
Biomedicines|October 23, 2021
Long-Term Pharmacokinetics of Dalbavancin in ABSSSI and Osteoarticular Settings: A Real-Life Outpatient ContextAmedeo De Nicolò, Giacomo Stroffolini, Miriam Antonucci, et al.
The Journal of Antimicrobial Chemotherapy|November 2, 2010
Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimensDaniel Gonzalez de Requena, Stefano Bonora, Ottavia Viganò, et al.
Pageof 36

Showing results (281-290 of 358) with videos related to

Sort By:
Pageof 36
International Journal of Antimicrobial Agents|February 4, 2021
Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses?Alice Trentalange, Enrica Borgogno, Ilaria Motta, et al.
AIDS Research and Human Retroviruses|July 14, 2015
HIV-1 Very Low Level Viremia Is Associated with Virological Failure in Highly Active Antiretroviral Treatment-Treated PatientsAndrea Calcagno, Ilaria Motta, Valeria Ghisetti, et al.
Antibiotics (Basel, Switzerland)|December 23, 2022
Pharmacokinetic of Cefiderocol in Critically Ill Patients Receiving Renal Replacement Therapy: A Case SeriesSimone Mornese Pinna, Silvia Corcione, Amedeo De Nicolò, et al.
Journal of Pharmacological and Toxicological Methods|August 31, 2018
A simple UHPLC-PDA method with a fast dilute-and-shot sample preparation for the quantification of canrenone and its prodrug spironolactone in human urine samplesValeria Avataneo, Amedeo De Nicolò, Franco Rabbia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From AntiretroviralsGuglielmo Nasti, Renato Talamini, Andrea Antinori, et al.
Current HIV Research|May 14, 2008
HIV-1 residual viremia and proviral DNA in patients with suppressed plasma viral load (<400 HIV-RNA cp/ml) during different antiretroviral regimensEmanuele Nicastri, Lucia Palmisano, Loredana Sarmati, et al.
AIDS (London, England)|November 26, 2019
Presence of Epstein-Barr virus DNA in cerebrospinal fluid is associated with greater HIV RNA and inflammationTommaso Lupia, Maria Grazia Milia, Cristiana Atzori, et al.
Pharmaceutics|September 23, 2022
Clinical Effectiveness and Pharmacokinetics of Dalbavancin in Treatment-Experienced Patients with Skin, Osteoarticular, or Vascular InfectionsGiacomo Stroffolini, Amedeo De Nicolò, Alberto Gaviraghi, et al.
Biomedicines|October 23, 2021
Long-Term Pharmacokinetics of Dalbavancin in ABSSSI and Osteoarticular Settings: A Real-Life Outpatient ContextAmedeo De Nicolò, Giacomo Stroffolini, Miriam Antonucci, et al.
The Journal of Antimicrobial Chemotherapy|November 2, 2010
Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimensDaniel Gonzalez de Requena, Stefano Bonora, Ottavia Viganò, et al.
Pageof 36